Myeloid Sarcoma

• CLINICAL_TRIALS research · 2026-03-13
  Clinical Trial Update: A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML [Phase 1]

  Phase 1 trial to assess the safety and tolerability of Ziftomenib in combination with Venetoclax/Azacitidine, Venetoclax alone, or 7+3 with …

• CLINICAL_TRIALS trial_result · 2025-11-20
  Clinical Trial Update: Dexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in Participants With Blood Cancers [Phase 2]

  Phase 2 trial evaluating Dexrazoxane hydrochloride to prevent heart-related side effects of chemotherapy in people with blood cancers; the s…

• CLINICAL_TRIALS research · 2025-08-12
  Clinical Trial Update: Provision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior Transplantation [Phase 2]

  This clinical trial update describes a Phase 2 study evaluating TCRγδ T cells and memory T cells with selective use of blinatumomab as part …

• CLINICAL_TRIALS research · 2025-07-09
  Clinical Trial Update: VAM in Secondary AML, AML With Extramedullary Involvement, and Myeloid Sarcoma [Phase 2]

  Phase 2 clinical trial evaluating the VAM regimen in secondary acute myeloid leukemia, AML with extramedullary involvement, and myeloid sarc…

• CLINICAL_TRIALS research · 2024-07-22
  Clinical Trial Update: Intensive Conditioning withTHI/Bu/Flu/Ara-C in Allo-HSCT for Myeloid Malignancies With Extramedullary Involvement

  This clinical trial is testing an intensive conditioning regimen consisting of Thiotepa, Busulfan, Fludarabine, and Cytarabine followed by a…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2020-07-07
  Clinical Trial Update: Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia [Phase 3]

  Phase 3 study evaluating the combination of bortezomib and sorafenib tosylate in newly diagnosed acute myeloid leukemia has posted results. …

• CLINICAL_TRIALS trial_result · 2020-07-07
  Clinical Trial Update: Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia [Phase 3]

  Phase 3 trial evaluating bortezomib with sorafenib tosylate in newly diagnosed acute myeloid leukemia has completed with results posted.

• CLINICAL_TRIALS trial_result · 2020-06-09
  Clinical Trial Update: Vosaroxin and Infusional Cytarabine in Treating Patients With Untreated Acute Myeloid Leukemia [Phase 2]

  Phase 2 clinical trial update evaluating vosaroxin with infusional cytarabine for untreated acute myeloid leukemia; results have been posted…

• CLINICAL_TRIALS trial_result · 2017-02-20
  Clinical Trial Update: T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant [Phase 2]

  Phase 2 trial of T-cell replete haploidentical donor hematopoietic stem cell transplantation with natural killer (NK) cell support in hemato…

• CLINICAL_TRIALS trial_result · 2016-05-02
  Clinical Trial Update: Repeat Transplantation for Relapsed or Refractory Hematologic Malignancies Following Prior Transplantation [Phase 2]

  Phase 2 clinical trial evaluating repeat transplantation for relapsed or refractory hematologic malignancies after prior transplant; the stu…